Drug Type Small molecule drug |
Synonyms VB-210, VITA-210 |
Target |
Action antagonists |
Mechanism CB2 antagonists(Cannabinoid CB2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Sclerosis | Preclinical | United States | 02 Nov 2016 | |
| Muscle Spasticity | Preclinical | United States | 02 Nov 2016 | |
| Fibromyalgia | Discovery | United States | 02 Nov 2016 | |
| Irritable Bowel Syndrome | Discovery | United States | 02 Nov 2016 | |
| Neuralgia | Discovery | United States | 02 Nov 2016 |





